Surrogate biomarkers and neoadjuvant endocrine therapy

被引：0
|
作者：
Ellis, MJ [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS | 2004年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：269 / 275
页数：7
相关论文
共 50 条
  • [21] Role of endocrine therapy in the neoadjuvant surgical setting
    J. Michael Dixon
    Annals of Surgical Oncology, 2004, 11 : 18S - 23S
  • [22] Neoadjuvant Endocrine Therapy: The Times They are A-Changing
    Mayer, I.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Neoadjuvant Endocrine Therapy: Who Benefits Most?
    Grossman, Julie
    Ma, Cynthia
    Aft, Rebecca
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (01) : 121 - +
  • [24] Neoadjuvant endocrine therapy: for whom, for how long?
    Fatima Cardoso
    Clinical and Translational Oncology, 2012, 14 : 81 - 82
  • [25] Neoadjuvant endocrine therapy: clinical and biological issues
    IE Smith
    Breast Cancer Research, 9
  • [26] Neoadjuvant use of endocrine therapy in breast cancer
    Macaskill, E. Jane
    Dixon, J. Michael
    BREAST JOURNAL, 2007, 13 (03): : 243 - 250
  • [27] Neoadjuvant Endocrine Therapy in Clinical Practice A Review
    Sella, Tal
    Weiss, Anna
    Mittendorf, Elizabeth A.
    King, Tari A.
    Pilewskie, Melissa
    Giuliano, Armando E.
    Metzger-Filho, Otto
    JAMA ONCOLOGY, 2021, 7 (11) : 1700 - 1708
  • [28] Neoadjuvant endocrine therapy: clinical and biological issues
    Smith, I. E.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [29] Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancer
    Jackisch, Christian
    LANCET ONCOLOGY, 2019, 20 (09): : 1185 - 1187
  • [30] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
12345